Duotir (Tirzepatide) Pre-filled syringe Injection

  • Duotir (Tirzepatide) Pre-filled syringe Injection 1
  • Duotir (Tirzepatide) Pre-filled syringe Injection 2
  • Duotir (Tirzepatide) Pre-filled syringe Injection 3
Product Description

Duotir® (Tirzepatide) is a pre-filled syringe injection manufactured by Opsonin Pharma Limited, Bangladesh. Available in 2.5 mg/0.5 mL, 5 mg/0.5 mL and 7.5 mg/0.5 mL strengths for subcutaneous administration. It is part of Opsonin's expanding metabolic portfolio. We are seeking distributors, importers and strategic partners for international markets. Meet Opsonin Pharma at CPHI Milan 2026 – Booth 20H75 to discuss potential collaboration.

Read more Show less

Opsonin Pharma

  • Country/Region:
    Bangladesh
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    5000+
Company types
Generics/Biosimilars Manufacturer
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Generic: Tirzepatide Dosage Form: Pre-filled Syringe Injection; Strengths: 2.5 mg/0.5 mL, 5 mg/0.5 mL & 7.5 mg/0.5 mL; 
    Route: Subcutaneous Injection; 
    Therapeutic Area: Metabolic / Type 2 Diabetes; 
    Manufacturer: Opsonin Pharma Limited, Bangladesh; \
    Business Opportunities: Distribution, Importation & Strategic Partnership
  • Selling Points
    Tirzepatide Pre-filled Syringe Injection available in 2.5 mg/0.5 mL, 5 mg/0.5 mL and 7.5 mg/0.5 mL strengths. Convenient pre-filled syringe presentation for subcutaneous administration. Manufactured by Opsonin Pharma Limited, Bangladesh, established in 1956. We are seeking distributors, importers and strategic partners for international markets. Meet us at CPHI Milan 2026 – Booth 20H75 to explore collaboration opportunities.
  • Model
    2.5 mg/0.5 mL | 5 mg/0.5 mL | 7.5 mg/0.5 mL Pre-filled Syringe Injections
More specifications Fewer specifications

Opsonin Pharma

  • Country/Region:
    Bangladesh
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    5000+
Company types
Generics/Biosimilars Manufacturer
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Opsonin Pharma (1)

  • Orforglipron Tablet

    Product Orforglipron Tablet

    Orforglipron is a first-in-class, once-daily oral non-peptide GLP-1 receptor agonist for chronic weight management and type 2 diabetes. 
    Orforglipron is a GLP-1 receptor agonist indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and m...

Opsonin Pharma resources (19)